메뉴 건너뛰기




Volumn 14, Issue 1, 2016, Pages

Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids

Author keywords

Breast cancer; In vitro diagnostics; Personalized medicine; Preclinical treatment selection; Spheroid cell culture

Indexed keywords

ANTHRACYCLINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; PACLITAXEL; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

EID: 84964781223     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-016-0855-3     Document Type: Article
Times cited : (41)

References (73)
  • 8
    • 78649825336 scopus 로고    scopus 로고
    • Current and emerging biomarkers in breast cancer: prognosis and prediction
    • Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer. 2010;17(4):R245-62.
    • (2010) Endocr Relat Cancer , vol.17 , Issue.4 , pp. R245-R262
    • Weigel, M.T.1    Dowsett, M.2
  • 10
    • 84887963281 scopus 로고    scopus 로고
    • Surrogate endpoints in metastatic breast cancer treated with targeted therapies: an analysis of the first-line phase III trials
    • Petrelli F, Barni S. Surrogate endpoints in metastatic breast cancer treated with targeted therapies: an analysis of the first-line phase III trials. Med Oncol. 2014;31(1):776.
    • (2014) Med Oncol , vol.31 , Issue.1 , pp. 776
    • Petrelli, F.1    Barni, S.2
  • 11
    • 84892943547 scopus 로고    scopus 로고
    • Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation
    • Chung C, Christianson M. Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation. J Oncol Pharm Pract. 2014;20(1):11-28.
    • (2014) J Oncol Pharm Pract , vol.20 , Issue.1 , pp. 11-28
    • Chung, C.1    Christianson, M.2
  • 12
    • 84886093926 scopus 로고    scopus 로고
    • A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer
    • Rutherford T, Orr J Jr, Grendys E Jr, Edwards R, Krivak TC, Holloway R, Moore RG, Puls L, Tillmanns T, Schink JC, et al. A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer. Gynecol Oncol. 2013;131(2):362-7.
    • (2013) Gynecol Oncol , vol.131 , Issue.2 , pp. 362-367
    • Rutherford, T.1    Orr, J.2    Grendys, E.3    Edwards, R.4    Krivak, T.C.5    Holloway, R.6    Moore, R.G.7    Puls, L.8    Tillmanns, T.9    Schink, J.C.10
  • 13
    • 84869502207 scopus 로고    scopus 로고
    • Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy
    • Houssami N, Macaskill P, von Minckwitz G, Marinovich ML, Mamounas E. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. Eur J Cancer. 2012;48(18):3342-54.
    • (2012) Eur J Cancer , vol.48 , Issue.18 , pp. 3342-3354
    • Houssami, N.1    Macaskill, P.2    Minckwitz, G.3    Marinovich, M.L.4    Mamounas, E.5
  • 17
    • 84889050826 scopus 로고    scopus 로고
    • Circulating tumor cells in HER2- positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
    • Liu Y, Liu Q, Wang T, Bian L, Zhang S, Hu H, Li S, Hu Z, Wu S, Liu B, et al. Circulating tumor cells in HER2- positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker. BMC Cancer. 2013;13:202.
    • (2013) BMC Cancer , vol.13 , pp. 202
    • Liu, Y.1    Liu, Q.2    Wang, T.3    Bian, L.4    Zhang, S.5    Hu, H.6    Li, S.7    Hu, Z.8    Wu, S.9    Liu, B.10
  • 19
    • 84918591788 scopus 로고    scopus 로고
    • Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer
    • Brown JR, Wimberly H, Lannin DR, Nixon C, Rimm DL, Bossuyt V. Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer. Clin Cancer Res. 2014;20(23):5995-6005.
    • (2014) Clin Cancer Res , vol.20 , Issue.23 , pp. 5995-6005
    • Brown, J.R.1    Wimberly, H.2    Lannin, D.R.3    Nixon, C.4    Rimm, D.L.5    Bossuyt, V.6
  • 20
    • 84920368791 scopus 로고    scopus 로고
    • TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer
    • Connolly RM, Leal JP, Goetz MP, Zhang Z, Zhou XC, Jacobs LK, Mhlanga J, JH O, Carpenter J, Storniolo AM, et al. TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer. J Nucl Med. 2015;56(1):31-7.
    • (2015) J Nucl Med , vol.56 , Issue.1 , pp. 31-37
    • Connolly, R.M.1    Leal, J.P.2    Goetz, M.P.3    Zhang, Z.4    Zhou, X.C.5    Jacobs, L.K.6    Mhlanga, J.7    Carpenter, J.8    Storniolo, A.M.9
  • 22
  • 23
  • 24
    • 84876691969 scopus 로고    scopus 로고
    • Ten-year analysis of the prospective multicentre chemo-n0 trial validates American Society Of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
    • Harbeck N, Schmitt M, Meisner C, Friedel C, Untch M, Schmidt M, Sweep CG, Lisboa BW, Lux MP, Beck T, et al. Ten-year analysis of the prospective multicentre chemo-n0 trial validates American Society Of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients. Eur J Cancer. 2013;49(8):1825-35.
    • (2013) Eur J Cancer , vol.49 , Issue.8 , pp. 1825-1835
    • Harbeck, N.1    Schmitt, M.2    Meisner, C.3    Friedel, C.4    Untch, M.5    Schmidt, M.6    Sweep, C.G.7    Lisboa, B.W.8    Lux, M.P.9    Beck, T.10
  • 25
    • 73249140371 scopus 로고    scopus 로고
    • Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
    • Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh IT, Ravdin P, Bugarini R, Baehner FL, Davidson NE, et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol. 2010;11(1):55-65.
    • (2010) Lancet Oncol , vol.11 , Issue.1 , pp. 55-65
    • Albain, K.S.1    Barlow, W.E.2    Shak, S.3    Hortobagyi, G.N.4    Livingston, R.B.5    Yeh, I.T.6    Ravdin, P.7    Bugarini, R.8    Baehner, F.L.9    Davidson, N.E.10
  • 26
    • 0141566685 scopus 로고    scopus 로고
    • Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models
    • Voskoglou-Nomikos T, Pater JL, Seymour L. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res. 2003;9(11):4227-39.
    • (2003) Clin Cancer Res , vol.9 , Issue.11 , pp. 4227-4239
    • Voskoglou-Nomikos, T.1    Pater, J.L.2    Seymour, L.3
  • 27
    • 84899726499 scopus 로고    scopus 로고
    • Use of rodents as models of human diseases
    • Vandamme TF. Use of rodents as models of human diseases. J Pharm Bioallied Sci. 2014;6(1):2-9.
    • (2014) J Pharm Bioallied Sci , vol.6 , Issue.1 , pp. 2-9
    • Vandamme, T.F.1
  • 28
    • 33645736793 scopus 로고    scopus 로고
    • Genetically engineered models have advantages over xenografts for preclinical studies
    • Becher OJ, Holland EC. Genetically engineered models have advantages over xenografts for preclinical studies. Cancer Res. 2006;66(7):3355-8 (discussion 3358-3359).
    • (2006) Cancer Res , vol.66 , Issue.7 , pp. 3355-3358
    • Becher, O.J.1    Holland, E.C.2
  • 32
    • 84893637270 scopus 로고    scopus 로고
    • One mouse, one patient paradigm: new avatars of personalized cancer therapy
    • Malaney P, Nicosia SV, Dave V. One mouse, one patient paradigm: new avatars of personalized cancer therapy. Cancer Lett. 2014;344(1):1-12.
    • (2014) Cancer Lett , vol.344 , Issue.1 , pp. 1-12
    • Malaney, P.1    Nicosia, S.V.2    Dave, V.3
  • 34
    • 79960015997 scopus 로고    scopus 로고
    • Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
    • Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Investig. 2011;121(7):2750-67.
    • (2011) J Clin Investig , vol.121 , Issue.7 , pp. 2750-2767
    • Lehmann, B.D.1    Bauer, J.A.2    Chen, X.3    Sanders, M.E.4    Chakravarthy, A.B.5    Shyr, Y.6    Pietenpol, J.A.7
  • 36
    • 84947237670 scopus 로고    scopus 로고
    • Molecular portrait of breast-cancer-derived cell lines reveals poor similarity with tumors
    • Cifani P, Kirik U, Waldemarson S, James P. Molecular portrait of breast-cancer-derived cell lines reveals poor similarity with tumors. J Proteome Res. 2015;14(7):2819-27.
    • (2015) J Proteome Res , vol.14 , Issue.7 , pp. 2819-2827
    • Cifani, P.1    Kirik, U.2    Waldemarson, S.3    James, P.4
  • 41
    • 84891404742 scopus 로고    scopus 로고
    • Organoid cultures for the analysis of cancer phenotypes
    • Sachs N, Clevers H. Organoid cultures for the analysis of cancer phenotypes. Curr Opin Genet Dev. 2014;24:68-73.
    • (2014) Curr Opin Genet Dev , vol.24 , pp. 68-73
    • Sachs, N.1    Clevers, H.2
  • 43
    • 84870569410 scopus 로고    scopus 로고
    • Three-dimensional culture of human breast epithelial cells: the how and the why
    • Vidi PA, Bissell MJ, Lelievre SA. Three-dimensional culture of human breast epithelial cells: the how and the why. Methods Mol Biol. 2013;945:193-219.
    • (2013) Methods Mol Biol , vol.945 , pp. 193-219
    • Vidi, P.A.1    Bissell, M.J.2    Lelievre, S.A.3
  • 44
    • 16544380146 scopus 로고    scopus 로고
    • The use of 3-D cultures for high-throughput screening: the multicellular spheroid model
    • Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen. 2004;9(4):273-85.
    • (2004) J Biomol Screen , vol.9 , Issue.4 , pp. 273-285
    • Kunz-Schughart, L.A.1    Freyer, J.P.2    Hofstaedter, F.3    Ebner, R.4
  • 45
    • 84892406857 scopus 로고    scopus 로고
    • Development of a high-throughput three-dimensional invasion assay for anti-cancer drug discovery
    • Evensen NA, Li J, Yang J, Yu X, Sampson NS, Zucker S, Cao J. Development of a high-throughput three-dimensional invasion assay for anti-cancer drug discovery. PLoS One. 2013;8(12):e82811.
    • (2013) PLoS One , vol.8 , Issue.12 , pp. e82811
    • Evensen, N.A.1    Li, J.2    Yang, J.3    Yu, X.4    Sampson, N.S.5    Zucker, S.6    Cao, J.7
  • 46
    • 79960001863 scopus 로고    scopus 로고
    • Effects of affinity on binding of HER2-targeting Affibody molecules: model experiments in breast cancer spheroids
    • Qvarnstrom OF, Simonsson M, Carlsson J, Tran TA. Effects of affinity on binding of HER2-targeting Affibody molecules: model experiments in breast cancer spheroids. Int J Oncol. 2011;39(2):353-9.
    • (2011) Int J Oncol , vol.39 , Issue.2 , pp. 353-359
    • Qvarnstrom, O.F.1    Simonsson, M.2    Carlsson, J.3    Tran, T.A.4
  • 47
    • 0023579733 scopus 로고
    • In vitro chemosensitivity testing using the multicellular tumor spheroid model
    • Kerr DJ, Wheldon TE, Kerr AM, Kaye SB. In vitro chemosensitivity testing using the multicellular tumor spheroid model. Cancer Drug Deliv. 1987;4(2):63-74.
    • (1987) Cancer Drug Deliv , vol.4 , Issue.2 , pp. 63-74
    • Kerr, D.J.1    Wheldon, T.E.2    Kerr, A.M.3    Kaye, S.B.4
  • 48
    • 84904008768 scopus 로고    scopus 로고
    • Engineering mammary gland in vitro models for cancer diagnostics and therapy
    • Campbell JJ, Hume RD, Watson CJ. Engineering mammary gland in vitro models for cancer diagnostics and therapy. Mol Pharm. 2014;11(7):1971-81.
    • (2014) Mol Pharm , vol.11 , Issue.7 , pp. 1971-1981
    • Campbell, J.J.1    Hume, R.D.2    Watson, C.J.3
  • 49
    • 79952264003 scopus 로고    scopus 로고
    • Multicellular spheroids as an in vitro model in experimental oncology: applications in translational medicine
    • Khaitan D, Dwarakanath BS. Multicellular spheroids as an in vitro model in experimental oncology: applications in translational medicine. Expert Opin Drug Discov. 2006;1(7):663-75.
    • (2006) Expert Opin Drug Discov , vol.1 , Issue.7 , pp. 663-675
    • Khaitan, D.1    Dwarakanath, B.S.2
  • 52
    • 0015762456 scopus 로고
    • A human cell line from a pleural effusion derived from a breast carcinoma
    • Soule HD, Vazguez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973;51(5):1409-16.
    • (1973) J Natl Cancer Inst , vol.51 , Issue.5 , pp. 1409-1416
    • Soule, H.D.1    Vazguez, J.2    Long, A.3    Albert, S.4    Brennan, M.5
  • 56
    • 84934970026 scopus 로고    scopus 로고
    • Highlights from the 14(th) St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer
    • Esposito A, Criscitiello C, Curigliano G. Highlights from the 14(th) St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer. Ecancermedicalscience. 2015;9:518.
    • (2015) Ecancermedicalscience , vol.9 , pp. 518
    • Esposito, A.1    Criscitiello, C.2    Curigliano, G.3
  • 58
    • 77951629946 scopus 로고    scopus 로고
    • Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study
    • von Minckwitz G, Rezai M, Loibl S, Fasching PA, Huober J, Tesch H, Bauerfeind I, Hilfrich J, Eidtmann H, Gerber B, et al. Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study. J Clin Oncol. 2010;28(12):2015-23.
    • (2010) J Clin Oncol , vol.28 , Issue.12 , pp. 2015-2023
    • Minckwitz, G.1    Rezai, M.2    Loibl, S.3    Fasching, P.A.4    Huober, J.5    Tesch, H.6    Bauerfeind, I.7    Hilfrich, J.8    Eidtmann, H.9    Gerber, B.10
  • 59
    • 0019217348 scopus 로고
    • In vitro adriamycin sensitivity test and hormonal receptors in primary breast cancer
    • Kaufmann M, Klinga K, Runnebaum B, Kubli F. In vitro adriamycin sensitivity test and hormonal receptors in primary breast cancer. Eur J Cancer. 1980;16(12):1609-13.
    • (1980) Eur J Cancer , vol.16 , Issue.12 , pp. 1609-1613
    • Kaufmann, M.1    Klinga, K.2    Runnebaum, B.3    Kubli, F.4
  • 61
    • 84953637912 scopus 로고    scopus 로고
    • Estrogen receptor alpha (ESR1)-signaling regulates the expression of the taxane-response biomarker PRP4K
    • Lahsaee S, Corkery DP, Anthes LE, Holly A, Dellaire G. Estrogen receptor alpha (ESR1)-signaling regulates the expression of the taxane-response biomarker PRP4K. Exp Cell Res. 2016;340(1):125-31.
    • (2016) Exp Cell Res , vol.340 , Issue.1 , pp. 125-131
    • Lahsaee, S.1    Corkery, D.P.2    Anthes, L.E.3    Holly, A.4    Dellaire, G.5
  • 62
    • 84931332357 scopus 로고    scopus 로고
    • Evaluation of chemotherapeutics in a three-dimensional breast cancer model
    • Lovitt CJ, Shelper TB, Avery VM. Evaluation of chemotherapeutics in a three-dimensional breast cancer model. J Cancer Res Clin Oncol. 2015;141(5):951-9.
    • (2015) J Cancer Res Clin Oncol , vol.141 , Issue.5 , pp. 951-959
    • Lovitt, C.J.1    Shelper, T.B.2    Avery, V.M.3
  • 63
    • 84930616832 scopus 로고    scopus 로고
    • Time-lapse imaging assay using the BioStation CT: a sensitive drug-screening method for three-dimensional cell culture
    • Sakamoto R, Rahman MM, Shimomura M, Itoh M, Nakatsura T. Time-lapse imaging assay using the BioStation CT: a sensitive drug-screening method for three-dimensional cell culture. Cancer Sci. 2015;106(6):757-65.
    • (2015) Cancer Sci , vol.106 , Issue.6 , pp. 757-765
    • Sakamoto, R.1    Rahman, M.M.2    Shimomura, M.3    Itoh, M.4    Nakatsura, T.5
  • 65
    • 84887042578 scopus 로고    scopus 로고
    • Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial
    • Denkert C, Loibl S, Muller BM, Eidtmann H, Schmitt WD, Eiermann W, Gerber B, Tesch H, Hilfrich J, Huober J, et al. Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial. Ann Oncol. 2013;24(11):2786-93.
    • (2013) Ann Oncol , vol.24 , Issue.11 , pp. 2786-2793
    • Denkert, C.1    Loibl, S.2    Muller, B.M.3    Eidtmann, H.4    Schmitt, W.D.5    Eiermann, W.6    Gerber, B.7    Tesch, H.8    Hilfrich, J.9    Huober, J.10
  • 69
    • 84908160897 scopus 로고    scopus 로고
    • A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial
    • Llombart-Cussac A, Pivot X, Biganzoli L, Cortes-Funes H, Pritchard KI, Pierga JY, Smith I, Thomssen C, Srock S, Sampayo M, et al. A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial. Breast. 2014;23(5):656-62.
    • (2014) Breast , vol.23 , Issue.5 , pp. 656-662
    • Llombart-Cussac, A.1    Pivot, X.2    Biganzoli, L.3    Cortes-Funes, H.4    Pritchard, K.I.5    Pierga, J.Y.6    Smith, I.7    Thomssen, C.8    Srock, S.9    Sampayo, M.10
  • 70
    • 84923673213 scopus 로고    scopus 로고
    • Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments
    • Stover DG, Wagle N. Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments. Curr Oncol Rep. 2015;17(4):15.
    • (2015) Curr Oncol Rep , vol.17 , Issue.4 , pp. 15
    • Stover, D.G.1    Wagle, N.2
  • 72
    • 84927551836 scopus 로고    scopus 로고
    • Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer
    • Bae SY, Kim S, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Lee JE, Nam SJ. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer. BMC Cancer. 2015;15:138.
    • (2015) BMC Cancer , vol.15 , pp. 138
    • Bae, S.Y.1    Kim, S.2    Lee, J.H.3    Lee, H.C.4    Lee, S.K.5    Kil, W.H.6    Kim, S.W.7    Lee, J.E.8    Nam, S.J.9
  • 73
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
    • Early Breast Cancer Trialists' Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687-717.
    • (2005) Lancet , vol.365 , Issue.9472 , pp. 1687-1717


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.